Metabolic and safety outcomes Regarding metabolic outcomes, combination therapy demonstrated significantly greater weight loss compared to SGLT-2i monotherapy (MD = 2.20, 95% CI 3.09
The federal government has cracked down on illegal sales and dangerous marketing tactics surrounding GLP-1 compounds
No matter which medication you choose, there should be at least minimal safety measures to follow
To this end, the development of new therapies, ideally targeting synovitis and inflammatory-related bone erosion in joints, as well as regulating those inflammation-independent factors that can also interfere with bone homeostasis in RA, such as the general RANKL signaling pathway, would be promising for remodeling bone homeostasis in RA
When you take semaglutide, it mimics the action of a natural hormone called GLP-1 in your body
In June, Zealand released positive data from an early trial showing that a high dose of the drug helped people lose nearly 9 percent of their body weight on average at 16 weeks